Predictive Oncology Reveals $344 Million in Private Placements
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Sep 29 2025
0mins
Should l Buy ?
Source: SeekingAlpha
Private Placement Transactions: Predictive Oncology announced two private placement transactions to raise approximately $344.4 million, involving the sale of common stock and pre-funded warrants for Aethir tokens.
Use of Proceeds: The funds will support the company's digital asset treasury strategy, including acquiring ATH tokens and covering working capital and corporate expenses, with the PIPEs expected to close around October 2, 2025.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
